It’s been just over a year since integrated care boards (ICBs) took on their statutory functions, and progress through collaboration in the area of medicines and pharmacy has been very positive. The publication in March 2023 of the new action plan on prescribed medicines associated with dependence or withdrawal symptoms was the culmination of close […]
This guidance describes the 16 national medicines optimisation opportunities for the NHS in 2023/24, and signposts to resources to help with their implementation. We recommend Integrated Care Boards (ICBs) choose at least five medicines optimisation opportunities to focus and deliver on alongside their local medicines optimisation priorities. Progress against chosen opportunities will be reviewed using available data.
Regional Medicines Optimisation Committees (RMOCs) have developed and published a number of advisory documents to help local teams with the prescribing of some medicines and implementation of new governance approaches. These documents provide safe and effective advice for the specified medicines or approaches outlined. Detail on each of the documents is included below: Free of […]
This updated supplementary guidance sets out the changes required to the service from April 2021, as per the requirements set out in the 2021/22 Network Contract Directed Enhanced Service (DES) Specification; which states that Primary Care Networks must have due regard to this guidance when delivering the service.
This document sets out guidance for primary care networks (PCNs) implementing the structured medication review (SMR) and medicines optimisation service, as per the requirements set out in the 2020/21 Network Contract Directed Enhanced Service (DES) Specification; which states that PCNs must have due regard to this guidance when delivering the service. It includes the principles of undertaking a SMR and should be read alongside the DES Specification and the Network Contract DES Guidance.
The purpose of the Medicines Optimisation Clinical Reference Group (MO CRG) is to provide advice to optimise the use of high cost medicines.
The first document sets out the detailed specification for the PSS1 Medicines Optimisation and Stewardship PSS CQUIN Indicator, which forms part of the 2019/20 Prescribed Specialised Services Commissioning for Quality and Innovation (CQUIN) scheme. The supporting documents give additional information relevant to the individual sub-indicators (payment triggers) that comprise this indicator.
Structured Medicine Reviews (SMRs) are an evidence-based and comprehensive review of a patient’s medication, taking into consideration all aspects of their health. In a structured medication review clinicians and patients work as equal partners to understand the balance between the benefits and risks of and alternatives of taking medicines. The shared decision-making conversation being led […]
This document describes the approach for “testing” the principles of a framework for NHS pharmacy and medicines integration within Sustainability and Transformation Partnership (STP) and Integrated Care System (ICS) pilot areas during 2018/19.